Cardiovascular disease and cancer are the leading causes of death in the U.S. and closely linked. Patients with cancer have increased risk of cardiovascular disease due to cardiac toxicities of some cancer therapies and shared risk factors between both conditions.

The Johns Hopkins Cardio-Oncology Program specializes in preventing and treating heart disease in patients undergoing cancer treatment and for cancer survivors.

Managing Cardiotoxicity

The Johns Hopkins Cardio-Oncology Program brings together experts in the fields of cardiology and oncology to provide timely and specialized cardiovascular care to oncology patients and survivors of all ages. Our approach includes:

• Providing a comprehensive cardiovascular risk assessment for identification of cancer patients who are at high risk for suffering cardiac toxicities from cancer therapies
• The use of advance imaging for early identification of changes in cardiac function during cancer treatment
• Long term follow up of cancer survivors who received cardiotoxic treatments for early identification and management of cardiovascular disease

Our comprehensive assessment may include:

• Health, life style, and family history assessment
• Electrocardiogram
• Echocardiogram
• Exercise tests
• Cardiac MRI
• Coronary Artery Calcium CT scan

Nurse Practitioners